搜索临床试验以:巩固(卡铂、多柔比星)-D1 组
总计276个结果
-
Shanghai Children's Medical CenterShanghai Children's Hospital招聘中
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)完全的
-
University of Texas Southwestern Medical CenterOrtho Biotech Clinical Affairs, L.L.C.撤销
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的卵巢癌 | 输卵管癌 | 原发性腹膜腔癌
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
King Faisal Specialist Hospital & Research Center完全的
-
THERAPIM PTY LTDNovotech (Australia) Pty Limited终止
-
Aprea Therapeutics完全的P53 突变的铂敏感复发性高级别浆液性卵巢癌美国, 法国, 西班牙, 荷兰, 英国, 比利时, 德国, 瑞典
-
AGO Study GroupEssex Pharma GmbH; MedServ. GmbH, Wiesbaden完全的
-
Konkuk University Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Asan Medical Center; Seoul National University... 和其他合作者完全的
-
University of Leicester未知
-
National Cancer Institute, Naples主动,不招人
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Medical University Innsbruck未知
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的卵巢癌 | 输卵管癌 | 原发性腹膜腔癌美国, 挪威
-
Tianjin Medical University Cancer Institute and...未知
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey主动,不招人IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Breast Cancer Research Foundation完全的
-
National Cheng-Kung University Hospital完全的输卵管癌 | 腹膜癌 | 卵巢恶性肿瘤(生殖细胞除外)
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca主动,不招人
-
St. Jude Children's Research HospitalNational Institutes of Health (NIH); Immunex/Berlex完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.完全的
-
Mario Negri Institute for Pharmacological ResearchPharmaMar; Averion International Corporation完全的
-
Merck Sharp & Dohme LLCPrincess Margaret Hospital, Canada完全的
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.终止
-
AGO Study GroupMerck Sharp & Dohme LLC完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 复发性子宫体癌 | III 期输卵管癌 AJCC v7 | III 期卵巢癌 AJCC v6 和 v7 | III 期原发性腹膜癌 AJCC v7 | III 期子宫体癌 AJCC v7 | IIIA 期输卵管癌 AJCC v7 | IIIA 期卵巢癌 AJCC v6 和 v7 | IIIA 期原发性腹膜癌 AJCC v7 | IIIA 期子宫体癌 AJCC v7 | IIIB 期输卵管癌 AJCC v7 | IIIB 期卵巢癌 AJCC v6 和 v7 | IIIB 期原发性腹膜癌 AJCC v7 | IIIB 期子宫体癌 AJCC v7 | IIIC 期输卵管癌 AJCC v7 | IIIC 期卵巢癌 AJCC... 及其他条件美国
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘评价安罗替尼联合同步放化疗治疗局部晚期宫颈癌的疗效和安全性
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Jiao Tong University...招聘中
-
Affiliated Cancer Hospital & Institute of Guangzhou...尚未招聘肺癌 | 放疗 | 广泛期小细胞肺癌
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical Limited完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的